These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15918985)

  • 1. [Treating chronic severe hepatitis B patients with mycophenolate mofetil].
    Yang YF; Tan DM; Xie YT; Lu MH; Liu ZB; Sha XP; Liu GZ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):392-3. PubMed ID: 15918985
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower 12-hour trough concentrations of mycophenolic acid in patients with active systemic vasculitides taking mycophenolate mofetil.
    Djabarouti S; Lazaro E; Breilh D; Pellegrin JL; Viallard JF
    J Rheumatol; 2012 Nov; 39(11):2222-3. PubMed ID: 23118295
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil therapy in a child with Churg-Strauss syndrome.
    Demircin G; Baysun S; Bülbül M; Erdoğan O; Oner A
    Pediatr Int; 2010 Jun; 52(3):e164-6. PubMed ID: 20723119
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
    Elliott JR; Manzi S
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
    [No Abstract]   [Full Text] [Related]  

  • 5. Orofacial granulomatosis successfully treated with mycophenolate mofetil.
    Antonyan AS; Pena-Robichaux V; McHargue CA
    J Am Acad Dermatol; 2014 Jun; 70(6):e137-9. PubMed ID: 24831337
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study.
    Radziwill AJ; Schweikert K; Kuntzer T; Fuhr P; Steck AJ
    Eur Neurol; 2006; 56(1):37-8. PubMed ID: 16914929
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B.
    Maes BD; van Pelt JF; Peeters JC; Nevens F; Evenepoel P; Kuypers D; Messiaen T; Fevery J; Vanrenterghem YF
    Transplantation; 2001 Sep; 72(6):1165-6. PubMed ID: 11579320
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil for the treatment of severe inflammatory external eye diseases.
    Wilkins MR; Dart JK
    Br J Ophthalmol; 2008 Apr; 92(4):578-9. PubMed ID: 18369079
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy.
    Nowack R; Birck R; van der Woude FJ
    Lancet; 1997 Mar; 349(9054):774. PubMed ID: 9074580
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin.
    Raghavendran RR; Humphreys F; Kaur MR
    Clin Exp Dermatol; 2014 Jan; 39(1):68-9. PubMed ID: 23692555
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil in patients with Crohn's disease.
    Fickert P; Hinterleitner TA; Wenzl HH; Aichbichler BW; Petritsch W
    Am J Gastroenterol; 1998 Dec; 93(12):2529-32. PubMed ID: 9860419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
    Rerolle JP; Szelag JC; Le Meur Y
    Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe Pneumocystis pneumonia in a renal transplant recipient after long term mycophenolate mofetil treatment.
    Totet A; Westeel PF; Nevez G
    Rev Inst Med Trop Sao Paulo; 2005; 47(5):303-4; author reply 305. PubMed ID: 16302116
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients.
    Köse O; Safali M; Bulent Tastan H; Gur AR
    Dermatology; 2004; 209(1):69-70. PubMed ID: 15237274
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura.
    Ahmad HN; Thomas-Dewing RR; Hunt BJ
    Eur J Haematol; 2007 May; 78(5):449-52. PubMed ID: 17331134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid treated with mycophenolate mofetil.
    Böhm M; Beissert S; Schwarz T; Metze D; Luger T
    Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.
    Gladstone DE; Golightly MG; Zamkoff KW
    Rheumatol Int; 2005 Oct; 25(8):635-6. PubMed ID: 15703955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.